key: cord-0285972-ezd2jgzw authors: Fischer, Marion F.S.; Crowe, James E.; Meiler, Jens title: Computational epitope mapping of class I fusion proteins using Bayes classification date: 2022-05-24 journal: bioRxiv DOI: 10.1101/2022.05.23.493016 sha: 856e1f8fd11f1e375cbe01663fb1c560cbdb4097 doc_id: 285972 cord_uid: ezd2jgzw Antibody epitope mapping of viral proteins plays a vital role in understanding immune system mechanisms of protection. In the case of class I viral fusion proteins, recent advances in cryo-electron microscopy and protein stabilization techniques have highlighted the importance of cryptic or ‘alternative’ conformations that expose epitopes targeted by potent neutralizing antibodies. Thorough epitope mapping of such metastable conformations is difficult, but is critical for understanding sites of vulnerability in class I fusion proteins that occur as transient conformational states during viral attachment and fusion. We introduce a novel method Accelerated class I fusion protein Epitope Mapping (AxIEM) that accounts for fusion protein flexibility to significantly improve out-of-sample prediction of discontinuous antibody epitopes. Harnessing data from previous experimental epitope mapping efforts of several class I fusion proteins, we demonstrate that accuracy of epitope prediction depends on residue environment and allows for the precise prediction of conformation-dependent antibody target residues. We also show that AxIEM can to identify common epitopes and provide structural insights for the development and rational design of vaccines. Author Summary Efficient determination of neutralizing epitopes of viral fusion proteins is paramount in the development of antibody-based therapeutics against rapidly evolving or undercharacterized viral pathogens. Advances in the determination of viral fusion proteins in multiple conformations with ‘cryptic epitopes’ during attachment and fusion has highlighted the importance of epitope accessibility due to viral fusion protein flexibility, a physical trait not accounted for in previous B-cell epitope prediction methods. Given the relatively limited number of viral fusion proteins that have been determined in multiple conformations that also have been extensively subjected to epitope mapping techniques,, which are predominantly class I fusion proteins, we chose a limited feature set in combination with a low-complexity Bayesian classifier model to avoid overfitting. We show that this model demonstrates higher accuracy in out-of-sample performance than publicly available epitope prediction methods. Additionally, due to limited structural annotation of neutralizing epitope residues, we provide examples of how our model better discerns conformation-specific epitopes, which is critical for subunit vaccine design, and how this may provide a novel approach to assess the structural changes of antigenicity of viral fusion protein homologues. Overview of AxIEM. For each residue within the dataset, a set of four features was calculated that 136 included three residue-specific features (outlined in red) and one environment feature (outlined in 137 dark yellow). Two of the residue specific features that measured relative solvent exposure (as 138 Neighbor Vector) and stability (as Rosetta Energy Unit) are unique to that residue as a part of a 139 single protein conformation. The feature measuring local displacements (as Contact Proximity 140 RMSD) quantifies a residue's contact changes within an ensemble, and relies on at least two We initially chose the metrics that calculated per-residue properties to avoid making 153 assumptions about epitope size or total antigenic surface area. Even though the mean per-residue 154 metric values were significantly different between epitope and non-epitope residues for NV, REU, 155 and CPRMSD, the overlapping coefficient η(31) was high with values of 0.733, 0.685, or 0.792, 156 respectively, indicating that each residue-specific feature has a relatively weak predictive value. 157 With the metric Neighbor Sum (NS), we found that increasing the radius size of the neighboring 158 residues' contributions to the NS value of a single residue resulted in a further separation of mean 159 NS values between experimentally determined epitope and non-epitope residues up to η = 0.333 at 160 a radius of 40 Å. Evaluation of the receiver operator characteristic (ROC) area under the curve 161 (AUC) values for each viral protein ensemble, however, indicated non-uniform maximal AUC 162 values given the upper boundary radius used to calculate NS, despite that cumulative maximal 163 performance converged when using an upper boundary radii greater than 32 Å (Fig 2) . We found 164 that maximal performance was strongly determined by the number of amino acids within each 165 conformation, with R 2 = 0.76 and p = 0.011 (S3 Fig). Using the linear regression model described 166 by the correlation of protein amino acid number n and maximal upper boundary performance u, with u = 15.1 + 0.0147n to determine the optimal upper boundary radius to calculate NS for each 168 protein ensemble, overall performance of the AxIEM method significantly outperformed existing 169 discontinuous epitope prediction methods, Discotope and Ellipro, as summarized in Table 1 . 170 171 Table 1 172 Performance evaluation summary of cumulative predictions. 173 within an ensemble, the residue was labeled as an expected negative for one conformation and 242 predicted to a positive, while also labeled as an expected positive in another conformation that was 243 predicted to be a negaitive. → represents the fraction of FN that were not labeled as 244 Table 2 Summary of false predictions. physicochemical proximity features in relation to the total number of residues within a fusion 305 protein ( Fig 2) . Given that AxIEM positive predictions tend to be clustered within local domains, 306 many of which are known to form epitope-paratope interactions with multiple neutralizing 307 antibodies, AxIEM may be better suited for the task of identifying conformation-specific sites of 308 vulnerability than the task of B-cell epitope prediction. In this case, subunit vaccine design 309 strategies might benefit from the construction of antigens that account for the relative structural 310 antigenicity of a fusion protein rather than the highly specific identification of a potential epitope 311 region. . residue's Cβ-Cβ distance (d) unit vector weighted by its likelihood to make a contact with the 320 reference residue, calculated as CP (Equation 1 ), and is normalized by the sum of all possible 321 contacts within the residue's vicinity, calculated as NC (Equation 2) . In other words, for a highly 322 buried residue, the weighted d unit vectors of all Cβ-Cβ distances will be directed outwards in many 323 directions so that its NV score ≈ ≅ 0, whereas a highly exposed residue's weighted unit vectors 324 will be directed uniformly so that its NV score ≅ 1. We use the lower and upper boundaries of 4.00 325 Å and 12.8 Å, respectively, because 4.00 Å was shown to be the optimal lower boundary to 326 accurately assess per-residue SASA using and 12.8 Å is the maximum length of a Cβ-Cβ 327 distance where any atom of one amino acid's side chain has been shown to make a direct 328 interaction with another amino acid's side chain (Equation 3) . where ⃗⃗⃗⃗ ‖⃗⃗⃗⃗ ‖ ⁄ is the unit vector of the jth residue multiplied by the CP score of the jth residue, 340 both terms in relation to the ith residue. single protein conformation was calculated with the Rosetta ref2015 energy function and using the 343 jd2_scoring application to estimate the single body and pairwise interaction energies of a residue 344 as the Rosetta per-residue total energy score, which is reported in Rosetta Energy Units (REU). 345 The metric CPRMSD has previously 346 been used to estimate the relative local side chain contact changes of a single residue experiences 347 as part of a protein ensemble, and was calculated as the sum of all root mean square deviations of 348 likely contacts a single residue will form (Equation 4)(29) . This was estimated by CP for each 349 Cβ-Cβ distance, again using 4.00 Å and 12.8 Å as the lower and upper boundaries. 350 where is the residue of interest, j is another residue in the same protein conformation, n is the 353 number of protein conformations within the protein ensemble, and ( ( ) ̅̅̅̅̅̅̅̅ − ( ) ) 2 is the 354 variance of the CP value of residue j with respect to residue i within n conformations. In the case 355 where only two conformations were used, only the mean CP value was calculated. 356 Neighbor Sum (NS) The NS metric was calculated as a weighted linear sum of NV, REU, and 357 CPRMSD (Equation 5). In the Results section, we reported NS using a fixed lower boundary of 358 4.00 Å and adjusted the upper boundary to test for epitope radius size as noted (Equation 6 ). We 359 also tested for adjusting the lower boundary to 6.00 Å and 8.00 Å as well as using a linear weighted 360 function instead of a cosine weighted function and found an increase in classification overlap of 361 NS values provided that the same upper boundary condition was used. indicating that RBD epitope similarity is relatively low between SARS-related 220 S proteins. Besides predicting experimentally determined RBD epitopes, AxIEM also predicted a 221 novel common site of vulnerability within the N-terminal domain (NTD) of the S1 subunit for both SARS-CoV-2 and SARS-CoV S proteins, although the sequence identity and alignment differed 223 for all predicted NTD epitope residues (Fig. 3C). Given these data Principles of Broad and Potent Antiviral Human Antibodies Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex 475 with HIV-1 Envelope Reveals a Combined Mode Pomegranate: fast and flexible probabilistic modeling in 535 python Measuring Distribution Similarities Between 537 Samples: A Distribution-Free Overlapping Index. Frontiers in 538 Psychology